COMPANY
Imaginostics
Funding and NIH signals
- SEC Form D raise Raised $40K (Form D filed May 29, 2026); +6 other Form D filings in the last 12 months. SEC Form D 0002122464-26-000008 (May 29, 2026)
Evidence (7 events)
- May 29, 2026 · SEC Form D 0002122464-26-000008
Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D; Filing date: 2026-05-29; Industry Group: Biotechnology; Date of First Sale: 2026-05-14; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer,typically preferred stock,upon the occurrence of specified triggering events including future financingroundS.); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 40000; Federal exemptions: 06b - Apr 6, 2026 · SEC Form D 0002122464-26-000004
Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D; Filing date: 2026-04-06; Industry Group: Biotechnology; Date of First Sale: 2021-11-20; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds.); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 500000; Federal exemptions: 06b || Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D/A; Filing date: 2026-04-08; Industry Group: Biotechnology; Date of First Sale: 2021-11-20; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds.); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 50000; Federal exemptions: 06b - Apr 6, 2026 · SEC Form D 0002122464-26-000005
Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D; Filing date: 2026-04-06; Industry Group: Biotechnology; Date of First Sale: 2024-02-03; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds.); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 5353594; Federal exemptions: 06b - Apr 6, 2026 · SEC Form D 0002122464-26-000006
Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D; Filing date: 2026-04-06; Industry Group: Biotechnology; Date of First Sale: 2022-09-06; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (These securities are convertible promissory notes that may convert into equity securities of the issuer, typically preferred stock, upon the occurrence of specified events, including qualified financing.); Business combination transaction: false; Total Offering Amount: 725274; Total Amount Sold: 725274; Federal exemptions: 06b - Apr 3, 2026 · SEC Form D 0002122464-26-000003
Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D; Filing date: 2026-04-03; Industry Group: Biotechnology; Date of First Sale: 2021-02-09; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds.); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 516900; Federal exemptions: 06b - Apr 3, 2026 · SEC Form D 0002122464-26-000002
Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D; Filing date: 2026-04-03; Industry Group: Biotechnology; Date of First Sale: 2020-09-03; Types of Securities Offered: Equity, Option/warrant, Security to be acquired, Other (These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer, typically preferred stock, upon the occurrence of specified triggering events, including future financing rounds.); Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 100000; Federal exemptions: 06b - Apr 3, 2026 · SEC Form D 0002122464-26-000001
Name of Issuer: IMAGINOSTICS, INC.; CIK: 2122464; Address: Orlando, FL; Submission type: D; Filing date: 2026-04-03; Industry Group: Biotechnology; Date of First Sale: 2018-07-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 400000; Federal exemptions: 06b
- May 29, 2026 · SEC Form D 0002122464-26-000008